Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2003
03/06/2003CA2459141A1 Delivery of disease control in aquaculture and agriculture using nutritional feeds containing bioactive proteins produced by viruses
03/06/2003CA2458972A1 Regulation of cytotrophoblast cell differentiation and cell migration
03/06/2003CA2458924A1 Casein derived peptides and uses thereof in therapy
03/06/2003CA2458866A1 Compositions and methods of treating diabetes
03/06/2003CA2458849A1 Obesity related genes expressed at least in the hypothalamus, liver or pancreas
03/06/2003CA2458640A1 Diagnosis, prevention and treatment of cancer
03/06/2003CA2458622A1 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto
03/06/2003CA2458574A1 Reagents and methods for smooth muscle therapies
03/06/2003CA2458565A1 New angiogenesis inhibitors based on soluble cd44 receptor hyaluronic acid binding domain
03/06/2003CA2458561A1 Yeast membrane protein expression system and its application in drug screening
03/06/2003CA2458559A1 Gene of novel corynebacterium diphtheriae antigen
03/06/2003CA2458506A1 Wild-type ras as a cancer therapeutic agent
03/06/2003CA2458448A1 Spontaneous emulsions containing cyclosporine
03/06/2003CA2458445A1 Extracellular messengers
03/06/2003CA2458443A1 Bioadhesive compositions and methods for enhanced mucosal drug absorption
03/06/2003CA2458394A1 Lipophilic drug compositions
03/06/2003CA2458381A1 Transmembrane protein differentially expressed in cancer
03/06/2003CA2458371A1 Glucagon-like peptide-1 analogs
03/06/2003CA2458261A1 Differentiation of neural stem cells and therapeutic use thereof
03/06/2003CA2458236A1 Gpi-anchored cytokines
03/06/2003CA2458226A1 Improved nitroreductase enzymes
03/06/2003CA2458132A1 Compositions comprising negatively charched phospholipids for treatment and/or prevention of macular degeneration and method for its manufacture
03/06/2003CA2457974A1 Combination preparations of aryl substituted propanolamine derivatives with other active ingredients and the use thereof
03/06/2003CA2457903A1 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer
03/06/2003CA2457885A1 Antimicrobial and anti-inflammatory peptides
03/06/2003CA2457879A1 Modulators of bone homeostasis identified in a high-throughput screen
03/06/2003CA2457779A1 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments
03/06/2003CA2457502A1 Gamma three protease
03/06/2003CA2457488A1 Antimicrobial agent
03/06/2003CA2456828A1 Novel genetic products from ashbya gossypii, associated with the structure of the cell wall or the cytoskeleton
03/06/2003CA2456323A1 Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
03/06/2003CA2455883A1 Anti-cancer and wound healing compounds
03/05/2003WO2002020566A2 NOVEL MMP-2 DERIVATIVES FOR USE AS INHIBITORS OF INTEGRIN αVβ¿3?
03/05/2003EP1288305A2 Plasma prekallikrein activation and kallikrein production assay
03/05/2003EP1288304A2 Self-assembled, defective, non-self-propagating viral particles
03/05/2003EP1288299A2 TRNA synthetase
03/05/2003EP1288298A2 TRNA synthetase from Staphylococcus aureus
03/05/2003EP1288297A1 Regulation of mt1-mmp activity
03/05/2003EP1288296A2 Method and reagent for inhibiting HBV viral replication
03/05/2003EP1288292A1 Long peptides of 22-40 amino acid residues that induce and/or enhance antigen specific immune responses.
03/05/2003EP1288228A1 BMP-2-derived peptides having osteogenetic activity and osteogenetic accelerator containing the same
03/05/2003EP1288227A1 Coactivator of nuclear receptors
03/05/2003EP1288226A1 Modification of the expression levels of Toll-like receptor familiy members for influencing neurodegeneration and neuroprotection in the human central nervous system
03/05/2003EP1288224A1 Therapeutic peptide derivatives
03/05/2003EP1288223A1 Therapeutic peptide derivatives
03/05/2003EP1288222A1 Peptidic compounds selectively binding to P-selectin
03/05/2003EP1288221A1 Oligopeptides
03/05/2003EP1287832A2 Use of leukemia inhibitory factor antagonist
03/05/2003EP1287830A1 Use of methioninase as an antitumor agent in anti-methionine chemotherapy
03/05/2003EP1287364A2 Diagnostics and therapeutics for macular degeneration-related disorders
03/05/2003EP1287362A2 Compositions and methods for modulating tumor specific expression
03/05/2003EP1287355A2 Methods and compounds for influencing $g(b)3 integrin-dependent intracellular processes
03/05/2003EP1287349A2 Method and apparatus for monitoring anti-platelet agents
03/05/2003EP1287159A1 Enzymatic treatment of whey proteins for the production of antihypertensive peptides, the resulting products and treatment of hypertension in mammals
03/05/2003EP1287157A1 Protein markers for pharmaceuticals and related toxicity
03/05/2003EP1287156A2 Tnf and ifn stimulated genes and uses therefor
03/05/2003EP1287147A2 Immunotoxin fusion proteins and means for expression thereof
03/05/2003EP1287142A1 Nucleic acid molecule comprising a nucleic acid sequence coding for an sdf-1 gamma chemokine, a neuropeptide precursor or at least one neuropeptide
03/05/2003EP1287141A2 Extracellular messengers
03/05/2003EP1287133A2 Regulation of human dopamine-like g protein-coupled receptor
03/05/2003EP1287130A2 Mammalian cytokine receptor subunit proteins, related reagents and methods
03/05/2003EP1287126A1 Ligands specific for an isoform of the prion protein
03/05/2003EP1287125A2 Dna sequences encoding dystrophin minigenes and methods of use thereof
03/05/2003EP1287124A2 Regulation of human epithin-like serine protease
03/05/2003EP1287122A2 Human pancreatic islet glucose-6-phosphatase
03/05/2003EP1287121A2 Extracellular domain of ryk protein for regulating angiogenesis
03/05/2003EP1287034A2 Derivatives of breast cancer antigen her-2 for therapeutical use
03/05/2003EP1287033A2 Pt32 sperm protein, sperm c-yes, oocyte cytoplasmic c-yes, and uses thereof
03/05/2003EP1287032A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
03/05/2003EP1287031A2 Polynucleotides encoding for polymorphic isoforms of the pthrp protein, the encoded proteins and their therapeutic applications thereof
03/05/2003EP1287029A2 Compositions and methods for the therapy and diagnosis of colon cancer
03/05/2003EP1287028A2 Compositions and methods for the therapy and diagnosis of colon cancer
03/05/2003EP1287027A2 Control of tgf(beta) signaling by km23 superfamily members
03/05/2003EP1287026A2 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
03/05/2003EP1287025A1 Sheep lice, bovicola ovis, allergen treatment
03/05/2003EP1287022A2 Human ion channels
03/05/2003EP1287021A2 Human galanin receptor-like g protein coupled receptor
03/05/2003EP1287020A2 Cancer diagnosis and assays for screening anti-cancer agents
03/05/2003EP1287019A1 Therapeutic approaches to diseases by suppression of the nurr subfamily of nuclear transcription factors
03/05/2003EP1287018A2 Thrombin inhibitors
03/05/2003EP1287015A1 Extracellular matrix polynucleotides, polypeptides, and antibodies
03/05/2003EP1286989A2 Prodrug of an ice inhibitor
03/05/2003EP1286974A2 Medicament for viral diseases
03/05/2003EP1286705A2 Bioconjugates of nanoparticles as radiopharmaceuticals
03/05/2003EP1286703A2 Methods and compounds for controlled release of recombinant parvovirus vectors
03/05/2003EP1286702A2 HMG CoA REDUCTASE INHIBITORS FOR PROMOTING ANGIOGENESIS
03/05/2003EP1286697A2 Method for selectively inhibiting ghrelin action
03/05/2003EP1286695A1 Antigenic composition comprising a polycationic peptide and inosine and cytosine
03/05/2003EP1286692A1 Intrathecal administration of rituximab for treatment of central nervous system lymphomas
03/05/2003EP1286691A2 Methods for treatment of diseases associated with inflammation under non-ischemic conditions
03/05/2003EP1286690A2 Use of alpha-msh and epo for preventing or treating ischemic conditions
03/05/2003EP1286689A1 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
03/05/2003EP1286688A2 A method of treatment of alzheimer's disease with a protein extractable from mammalian organs
03/05/2003EP1286687A2 A method of treatment of huntington's chorea with a protein extractable from mammalian organs
03/05/2003EP1286686A2 Methods for preventing strokes by inducing tolerance to e-selectin
03/05/2003EP1286685A2 A method of treatment of parkinson's disease with a protein extractable from mammalian organs
03/05/2003EP1286684A2 Cxcr4 antagonist treatment of hematopoietic cells
03/05/2003EP1286683A2 A method of treatment of amyotrophic lateral sclerosis with a protein extractable from mammalian organs
03/05/2003EP1286679A1 Skin treatment preparation
03/05/2003EP1286678A2 Combination of a mutant herpes virus and a chemotherapeutic agent for the treatment of cancer
1 ... 1894 1895 1896 1897 1898 1899 1900 1901 1902 1903 1904 1905 1906 1907 1908 1909 1910 1911 1912 1913 1914 ... 3163